Find policies, billing codes, payers, states, and providers
CPT 81109: HPA-5 (K505E) Genetic Analysis
CPT code 81109 represents a molecular diagnostic laboratory test that analyzes the HPA–5 (K505E) alleles to determine platelet antigen status. This genetic analysis has clinical relevance for transfusion medicine, platelet compatibility assessment, and certain prenatal scenarios where fetal platelet antigen typing may inform clinical decisions. Nationally, such targeted genetic tests contribute to precision transfusion practices and perinatal risk assessment.
Key payers included in the coverage discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, how and where the test is typically performed, and the practical implications for laboratory services. The publication also summarizes benchmarking and coverage considerations, coding and billing basics, and common clinical scenarios in which CPT code 81109 is used.
This resource is intended to provide a clear, national-level briefing on the purpose of CPT code 81109, the clinical settings in which the test is ordered, and the types of information stakeholders should expect when evaluating laboratory genetic testing for HPA–5 (K505E). Data not available in the input will be noted where applicable.
Customize your policy alerts
Sign up for cpt 81109 policy alerts
Get alerted when payer policies referencing 81109 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 81109 describes a laboratory molecular diagnostic test that analyzes the genes for the two common alleles of Human Platelet Antigen 5 (HPA–5), also known as K505E, using a biological specimen such as blood or amniotic fluid. The procedure involves technical laboratory work to identify allele variants relevant to platelet antigen status.
-
Service type: Molecular diagnostic genetic test (technical component)
-
Typical site of service: Clinical laboratory or reference molecular diagnostics laboratory; specimen collection may occur in outpatient phlebotomy settings or obstetric care settings for amniotic fluid specimens.